Property:Financial Disclosures
From EyeWiki
This property has type text.
D
"None" +
V
"None" +
J
V
S
1. Consultant, Alcon +
M
AMO-Abbott, Allergan, Bausch & Lomb, Inspire, Vistakon, Santen, Pfizer, FOCUS Laboratories, Aton Pharma, Ocularis Pharma, Ace Vision Group, VISION3 +
B
AbbVie (Consultant, Speaker)
Alcon (Consultant, Speaker)
CorneaGen( Consultant)
Dompe (Consultant)
Glaukos (Consultant) +
J
Acufocus, Bausch + Lomb, Johnson & Johnson Vision, Shire, TearLab +
D
Ad hoc consultant for Alcon, Alimera, Bausch & Lomb, Genentech, Glaukos, and Thrombogenics +
Advisor/Consultant: Astellas, Apellis, Alimera Sciences, EyePoint Pharmaceuticals, Genentech, Regeneron, ONL Therapeutics, Verana Health,
Speaker: Astellas +
N
Advisory Board, Alimera Sciences
Advisory Board, Allergan
Advisory Board, Optos +
A
Advisory Board, Immunocore +
Aerie Pharmaceuticals (S), New World Medical, Inc (C) +
Alcon (Consultant),
Allergan (Consultant, Investigator),
Aerie (Consultant, Investigator),
IQVIA (Data Safety Monitor) +
S
Alcon (speaker) +
P
Alcon (speaker)
Inspire (speaker)
Pfizer (consultant)
Johnson & Johnson (advisory board)
Bausch & Lomb (advisory board)
Paragon (speaker)
Vistakon (speaker) +
S
Alcon - patent royalties.
Genentech - consultant.
Allergan - consultant. +
K
Alcon Laboratories
Johnson & Johnson Vision +
P
Alcon Laboratories - Research Support +
R
Alcon Laboratories, Inc. (L)
Allergan (S)
Carl Zeiss Meditec (S)
Novartis Pharmaceuticals Corporation (C,L) +